Ignite Creation Date:
2025-12-24 @ 2:46 PM
Ignite Modification Date:
2026-01-16 @ 11:33 AM
Study NCT ID:
NCT01682759
Status:
COMPLETED
Last Update Posted:
2018-09-07
First Post:
2012-09-07
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study of the Safety and Efficacy of Omarigliptin (MK-3102) Compared With Glimepiride in Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin (MK-3102-016)
Sponsor:
Merck Sharp & Dohme LLC
Organization: